Literature DB >> 2332537

Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction.

M Bernasconi1, R Brandolese, R Poggi, E Manzin, A Rossi.   

Abstract

To investigate the dose-response relationship and the time course of the effects of fenoterol (a selective beta 2-adrenergic agonist) on respiratory function in mechanically ventilated patients with acute respiratory failure due to exacerbation of chronic airflow obstruction (CAO), seven consecutive acutely ill patients were studied within 3 days of the onset of mechanical ventilation. Airflow, airway pressure, and changes in lung volume were measured with the transducers of the 900 C Servo Ventilator, the last by electronic integration. The end-expiratory lung volume (EELV), the intrinsic positive end-expiratory pressure (PEEPi), the static respiratory compliance (Cstrs), maximum and minimum respiratory resistance (Rrsmax and Rrsmin), and arterial oxygen tension (PaO2), were measured under control conditions (all patients were receiving aminophylline infused at a constant rate) 5, 15, and 30 min after administration of 4 ml aerosolized saline solution and 5, 15, and 30 min after inhalation of 0.4, 0.8, and 1.2 mg fenoterol. After the last dose, measurements were repeated at 60, 120, and 180 min. We found that, on average, while saline did not cause any significant change in respiratory mechanics, a low dose (0.4 mg) of inhaled fenoterol was followed by a rapid (5 min) and significant decrease in Rrsmax (-33%), Rrsmin (-28%), EELV (-34%), and PEEPi (-44%), with a slight but not significant further fall with higher doses. However, changes were short-lasting, and by 2 h after the end of administration were no longer significant. PaO2 dropped significantly on average, with a maximum mean fall of 15 mmHg.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332537     DOI: 10.1007/bf02575304

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  7 in total

Review 1.  Intrinsic positive end-expiratory pressure (PEEPi).

Authors:  A Rossi; G Polese; G Brandi; G Conti
Journal:  Intensive Care Med       Date:  1995-06       Impact factor: 17.440

2.  What role for theophylline?

Authors:  J W Jenne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

3.  Aerosol therapy during mechanical ventilation: an international survey.

Authors:  Stephan Ehrmann; Ferran Roche-Campo; Giuseppe Francesco Sferrazza Papa; Daniel Isabey; Laurent Brochard; Gabriela Apiou-Sbirlea
Journal:  Intensive Care Med       Date:  2013-03-23       Impact factor: 17.440

4.  Comparative effects of helium-oxygen and external positive end-expiratory pressure on respiratory mechanics, gas exchange, and ventilation-perfusion relationships in mechanically ventilated patients with chronic obstructive pulmonary disease.

Authors:  Philippe Jolliet; Christine Watremez; Jean Roeseler; J C Ngengiyumva; Marc de Kock; Thierry Clerbaux; Didier Tassaux; Marc Reynaert; Bruno Detry; Giuseppe Liistro
Journal:  Intensive Care Med       Date:  2003-07-08       Impact factor: 17.440

5.  Elevated static compliance of the total respiratory system: early predictor of weaning unsuccess in severed COPD patients mechanically ventilated.

Authors:  E Zanotti; F Rubini; G Iotti; A Braschi; A Palo; C Bruschi; C Fracchia; S Nava
Journal:  Intensive Care Med       Date:  1995-05       Impact factor: 17.440

6.  Duration of salmeterol-induced bronchodilation in mechanically ventilated chronic obstructive pulmonary disease patients: a prospective clinical study.

Authors:  Polychronis Malliotakis; Manolis Linardakis; George Gavriilidis; Dimitris Georgopoulos
Journal:  Crit Care       Date:  2008-11-14       Impact factor: 9.097

7.  Modeling the effectiveness of nebulized terbutaline for decompensated chronic obstructive pulmonary disease patients in the emergency department.

Authors:  Florian Gueho; Sébastien Beaune; Philippe Devillier; Saik Urien; Christophe Faisy
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.